Imagen de Portada

Efficacy of dupilumab in palmoplantar pustulosis treatment highlights the role of Th2 inflammation

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Yu‐Xin Zheng, Xi‐Bei Chen, Zhao‐Yuan Wang, Sui‐Qing Cai, Min Zheng, Li Fang Koh, John E. Common, Xiao‐Yong Man
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	Allergy
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Single‐cell profiling highlight pathogenic myeloid features in house dust mite‐induced murine model of airway inflammation
por: Jiachen Liu, et al.
Publicado: (2024)

Evaluation of dupilumab and benralizumab on peripheral airway resistance and reactance
por: Rory Chan, et al.
Publicado: (2024)

Differential modulation of allergic rhinitis nasal transcriptome by dupilumab and allergy immunotherapy
por: Matthew F. Wipperman, et al.
Publicado: (2024)

Effects of dupilumab on quality of life burden in refractory type 2 high unified airway disease
por: Kirsten E. Stewart, et al.
Publicado: (2024)

Eosinophilia, atopic dermatitis, and dupilumab: A potentially dangerous liaison?
por: Yung‐Yi Lan, et al.
Publicado: (2026)

Suppressed IgG4 class switching in dupilumab‐ and TNF inhibitor‐treated patients after mRNA vaccination
por: Anika M. Valk, et al.
Publicado: (2024)

The skin microbiome in pediatric atopic dermatitis and food allergy
por: Elizabeth Huiwen Tham, et al.
Publicado: (2024)

Unveiling a suspected dupilumab‐induced neuropathy in pediatric eosinophilic esophagitis
por: Hugo Gagnon, et al.
Publicado: (2024)

Real‐world data show sustained therapeutic effects of dupilumab in chronic rhinosinusitis with nasal polyps (CRSwNP) over 3 years
por: Patrick Huber, et al.
Publicado: (2024)

Intestinal Fibroblasts Orchestrate IL ‐4‐Driven Th2 Polarisation in Food Allergy via Paracrine Signalling and Nanotherapeutic Targeting
por: Botang Guo, et al.
Publicado: (2025)

Use of dupilumab for atopic dermatitis in pediatric and young adult patients with inborn errors of immunity
por: Paola Zangari, et al.
Publicado: (2024)

More than half of chronic rhinosinusitis with nasal polyps (CRSwNP) patients treated with dupilumab experience early and fast olfactory improvement within 28 days
por: Josje Janna Otten, et al.
Publicado: (2024)

Allergic inflammation triggers dyslipidemia via IgG signalling
por: Nieves Fernández‐Gallego, et al.
Publicado: (2024)

T cell immunophenotypes and IgE responses in patients with moderate‐to‐severe atopic dermatitis receiving dupilumab
por: Davender Redhu, et al.
Publicado: (2025)

Off‐label use of dupilumab in the management of pediatric urticaria vasculitis: A promising therapeutic choice
por: Shan Wang, et al.
Publicado: (2025)

Associations of tenascin C with Th2 response, edema degree, and disease severity in patients with chronic rhinosinusitis with nasal polyps
por: Min Wang, et al.
Publicado: (2024)

Therapeutic relevance of eosinophilic inflammation and airway viral interactions in severe asthma
por: Hitasha Rupani, et al.
Publicado: (2024)

NLRC4 Regulates Th2 Differentiation in Mice With Allergic Airway Inflammation Induced by House Dust Mite
por: So‐Won Pak, et al.
Publicado: (2025)

Perioperative adjuvant therapy with short course of dupilumab with ESS for recurrent CRSwNP
por: Audrey Pelletier, et al.
Publicado: (2024)

Real‐world predictors of dupilumab prescription in patients with chronic rhinosinusitis with nasal polyps
por: Christina Dorismond, et al.
Publicado: (2024)

Efficacy and safety of a 7‐week immunotherapy protocol with aluminium hydroxide adsorbed hymenoptera venom
por: Bogusia Kasternow, et al.
Publicado: (2024)

Tissue‐specific contribution of mucosal‐associated invariant T cells to allergic airway inflammation
por: Alissa Cait, et al.
Publicado: (2024)

Prevention of allergic airway and gut inflammation in humanized mice by lactobacilli, bifidobacteria, and butyrate
por: Rahul Khatri, et al.
Publicado: (2024)

Efficacy and Safety of Biologics for Chronic Rhinosinusitis With Nasal Polyps: A Meta‐Analysis of Real‐World Evidence
por: Shiru Cai, et al.
Publicado: (2025)

Atopic dermatitis in children: Untargeted proteomics highlights the interaction between barrier dysfunction and immune dysregulation as key pathways
por: Sean Wee, et al.
Publicado: (2025)

Pre‐existing inflammation reduces the response to contact allergens in Tmem79‐deficient mice
por: Mia Hamilton Jee, et al.
Publicado: (2024)

Regulatory T cells and their role in allergic disease
por: Melanie L. Conrad, et al.
Publicado: (2024)

Higher prevalence of dupilumab‐induced ocular adverse events in atopic dermatitis compared to asthma: A daily practice analysis
por: Anne R. Schlösser, et al.
Publicado: (2024)

Type 2 inflammation in cystic fibrosis is a predictor of mortality and targeted with CFTR modulator therapy
por: Daniel P. Cook, et al.
Publicado: (2024)

Efficacy and Safety Profile of Animal Dander Immunotherapy: A Multicentre UK Study
por: Da‐In S. Kim, et al.
Publicado: (2025)

Real‐World Efficacy and Safety of Abrocitinib in Chinese Atopic Dermatitis Patients: A Single‐Center Prospective Study
por: Zheng Li, et al.
Publicado: (2025)

Differential decline of SARS‐CoV‐2‐specific antibody levels, innate and adaptive immune cells, and shift of Th1/inflammatory to Th2 serum cytokine levels long after first COVID‐19
por: Bernhard Kratzer, et al.
Publicado: (2024)

Succinate induces a Th2 environment in the small intestine but does not exacerbate food allergy
por: Jian Tan, et al.
Publicado: (2024)

Neutrophil‐driven and interleukin‐36γ‐associated ocular surface inflammation in chronic Stevens–Johnson syndrome
por: Madhuri Amulya Koduri, et al.
Publicado: (2024)

Interleukin‐5 as a pleiotropic cytokine orchestrating airway type 2 inflammation: Effects on and beyond eosinophils
por: Kathleen M. Buchheit, et al.
Publicado: (2024)

Interplay of a well‐known medication and newly discovered transporters driving bacteria‐induced inflammation in psoriasis
por: Greta Lücke
Publicado: (2024)

Efficacy of upadacitinib in palmoplantar pustulosis case series highlights the complex immune response patterns
por: Shao‐Zhen Mai, et al.
Publicado: (2026)

A Phenotypically Distinct Human Th2 Cell Subpopulation Is Associated With Development of Allergic Disorders in Infancy
por: Catherine R. Pizzarello, et al.
Publicado: (2025)

Correction to “Mind and skin: Exploring the links between inflammation, sleep disturbance and neurocognitive function in patients with atopic dermatitis”
Publicado: (2024)

Targeting IL‐13 with tralokinumab normalizes type 2 inflammation in atopic dermatitis both early and at 2 years
por: Emma Guttman‐Yassky, et al.
Publicado: (2024)